Authors
Latest:
The Influence of Provider Characteristics and Market Forces on Response to Financial IncentivesWe determine a specialist physician phenotype responsive to financial incentives that may be leveraged to identify physicians and markets well-suited for participation in alternative payment models.
Latest:
Substitutive Hospital at Home for Older Persons: Effects on CostsSubstitutive Hospital at Home care for 4 common conditions is associated with cost savings.
Latest:
The Emerging Business Models and Value Proposition of Mobile Health ClinicsMobile health clinics represent promising vehicles through which high quality, cost-effective care can be delivered to patients, especially in underserved areas.
Latest:
Cost-Effectiveness of Pharmacist Postdischarge Follow-Up to Prevent Medication-Related AdmissionsA multivariable sensitivity analysis conducted on a pharmacy follow-up program of high-risk patients demonstrated cost savings to hospitals in 98.3% of head-to-head trials across 1000 hypothetical hospitals.
Latest:
Effect of Physician-Specific Pay-for-Performance Incentives in a Large Group PracticeThis study examined the effect of physician-specific pay-for-performance incentives on well-established ambulatory quality measures in a large group practice setting.
Latest:
Cost of Pharmacotherapy for Opioid Use Disorders Following Inpatient DetoxificationThe mean 24-week cost per participant was $5416 for extended-release injectable naltrexone (57% detoxification, 37% medication, 6% provider/patient) and $4148 for buprenorphine-naloxone (64% detoxification, 12% medication, 24% provider/patient).
Latest:
Breast Cancer Multigene Testing Trends and Impact on Chemotherapy UseA multigene test for breast cancer recurrence risk was used in a minority of eligible patients, yet was associated with a decrease in chemotherapy use.
Latest:
Medical Home Transformation and Breast Cancer ScreeningBreast cancer screening may not improve in early medical home implementation.
Latest:
Guided Care and the Cost of Complex Healthcare: A Preliminary ReportThe early months of a cluster-randomized trial suggest that Guided Care is associated with a trend toward a net reduction in total healthcare expenditures.
Latest:
Patient Factors Associated With Following a Relocated Primary Care Provider Among Older AdultsThere are differences between patients who elect to maintain continuity with their PCP versus those who choose to change their PCP for convenience.
Latest:
The Implementation of Opioid Prescribing Report Cards in Medicaid Managed Care: A Community Quality CollaborativeThis article describes the Philadelphia Medicaid Opioid Prescribing Initiative that was launched by a multidisciplinary team and mailed local Medicaid providers individualized prescribing report cards.
Latest:
Health Information Technology and Physicians' Perceptions of Healthcare QualityHealth information technology can enhance physicians' ability to provide high-quality care, suggesting that physicians should use it more extensively in their practices.
Latest:
Addressing Oncologists' Gaps in the Use of Biosimilar ProductsThe availability of biosimilar products may improve access to healthcare by increasing the number of therapeutic options available at potentially lower costs. As of April 2019, 18 such biological products had been approved by the FDA, including 4 biosimilars for trastuzumab, 3 each for infliximab and adalimumab, 2 each for pegfilgrastim and filgrastim, and 1 each for rituximab, epoetin alfa, bevacizumab, and etanercept. The pace of approvals has accelerated, from the first indication for a filgrastim biosimilar in 2015 to 3 approvals in 2016, 5 in 2017, and 9 through early 2019, 7 of which were announced in the 2018 calendar year.
Latest:
Budget Impact Analysis of 8 Hormonal Contraceptive OptionsA model assessing 8 hormonal contraceptive methods found that lower pregnancy costs for the etonogestrel implant and levonorgestrel intrauterine device offset their higher acquisition costs.
Latest:
Improving the Outcomes of Disease Management by Tailoring Care to the Patient's Level of ActivationTailoring coaching to each patient’s activation level may improve clinical indicators and reduce utilization more than the usual disease management coaching.
Latest:
VHA Pharmacy Use in Veterans With Medicare Drug CoverageGreater Medicare managed care benefit levels reduce both the likelihood and magnitude of Veterans Health Administration pharmacy use by Medicare dually enrolled veterans.
Latest:
Characteristics of Accountable Care Organizations’ Preferred Skilled Nursing Facility NetworksMedicare accountable care organizations use preferred skilled nursing facility networks for postacute care management, although the size, structure, and resource allocation of networks vary widely.
Latest:
Changing Trends in Type 2 Diabetes Mellitus Treatment Intensification, 2002-2010Glycemic control can lower the risk of diabetes-related complications, and delayed treatment intensification can impede optimal diabetes care.This study examines trends in hyperglycemia treatment intensification between 2002 and 2010.
Latest:
The Effect of a Cardiovascular Educational Intervention on Healthcare Utilization and CostsA low-cost cardiovascular disease screening and periodic educational intervention did not increase healthcare resource utilization and expenditures at 1 year.
Latest:
Retail Clinic Versus Office Setting: Do Patients Choose Appropriate Providers?Care episodes treated in retail clinics appeared to be less complex than those treated in office settings.
